Barry joined Pappas Capital in 2004 as an Executive-in-Residence, becoming a Venture Partner in 2022. His experience and background enable him to bring a deep knowledge of medical devices, business and clinical practice to the table.
Barry has been a member of the Duke University faculty for 31 years, currently serving as Director of Innovation in the Duke Clinical Translational Science Institute, and as the Coulter Program Director where he manages seed funding to help commercialize Duke faculty innovation. He is also a professor of Biomedical Engineering, with appointments in Surgery and Business Administration. Barry has considerable experience in both business and academic leadership, having served as Managing Director of the Duke Office of Licensing and Ventures. He is recognized as a world leader in injury research and product safety, with over 100 publications. In addition to his roles at Pappas Ventures and Duke, Barry maintains an active consulting practice, advising clients including the NFL, NASCAR and most major automotive manufacturers and US federal organizations concerned with product safety. Barry previously served as a board observer for Pappas Ventures III portfolio companies Gentis and TYRX.
University of Toronto (BS in Mechanical Engineering)
Duke University (MD)
Duke University (PhD in Biomedical Engineering)
Duke University (MBA)
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.